Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Early Diagnostic Biomarkers for Depression: Insights from Proteomic Analysis

ABSTRACT: We conducted a comprehensive proteomic analysis of patients with major depressive disorders and healthy controls matched for age and gender (n=20 per group).

ORGANISM(S): Homo Sapiens

SUBMITTER: Guofu Zhang

PROVIDER: PXD058722 | iProX | Tue Dec 10 00:00:00 GMT 2024

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Immunological subtypes of depression: insights from monocyte gene expression

Project description:32 genes of a previously established inflammation-related gene signature were assessed in 197 patients with MDD and 151 controls collected during the EU-MOODINFLAME project. Monocyte gene expression data were related to age, gender, BMI, depression severity, Childhood Adversity (CA), and Suicide Risk (SR) data studycenter 1

2020-03-27 | GSE147582 | GEO

Immunological subtypes of depression: insights from monocyte gene expression II

2020-03-27 | GSE147583 | GEO

Immunological subtypes of depression: insights from monocyte gene expression III

2020-03-27 | GSE147584 | GEO

Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington’s Disease Progression

Project description:This is a case control study consisting of 36 HD patients, more specifically of asymptomatic (n=18), early symptomatic (n=10) and symptomatic advanced (n=8) and 36 gender/age matched controls. A blood sample was collected from all study participants, using a standard protocol serum was extracted and stored at -80°C degrees until time of sample preparation and analysis.

2025-08-04 | PXD053477 | Pride

Healthy aging of skeletal muscle: Insights from a combined morphological and multiomic study

Project description:This study shows age-related differences in the molecular signatures of healthy skeletal muscle. Moreover, the findings assert that processes previously associated solely with aging and sarcopenia are indeed part of healthy aging. Additionally, the data underscores the importance of using appropriate age-matched controls for multi-omic molecular profiling of muscular disorders.

2024-10-09 | GSE257558 | GEO

Metabolomics Workbench ST000063 - GNPS - Biomarkers for Depression in Human Cerebrospinal Fluid in a Population Sample

Project description:This West Coast Metabolomics Center pilot and feasibility project was granted to Roel Ophoff (UC Los Angeles ) and Steve Horwath (UC Los Angeles ) . Major depressive disorder (MDD) is one of the most debilitating disorders in the United States with a 12-month prevalence of 6.7% in the adult population. The disorder affects millions of Americans daily and is a major health concern with enormous economic cost the society at large. Criteria for MDD diagnosis and treatment are based on various signs and symptoms not always fitting into strict diagnostic categories such as DSM-IV. Despite various known risk factors (such as family history, age, and gender), biological markers supporting diagnosis or prediction of MDD are unavailable. We have collected cerebrospinal fluid (CSF) and peripheral blood of more than 600 subjects from the general population. For each of the participants we also obtained biometric information as well as behavioral trait measures. One of the measures is the Beck Depression Inventory (BDI), a well-established questionnaire for measuring severity of depression. Based on the BDI, roughly 5% of participants suffer from severe depressive symptoms while most of these subjects are not under treatment or receiving any medication for depression In the current investigation, untargeted analysis of primary metabolites was conducted on age and gender matched human cerebrospinal fluid (CSF) and plasma from subjects suffering with MDD ( n=50) and control subjects (n=50). Subjects were diagnosed as having MDD based on the Beck Depression Inventory. The primary objectives of this study were to 1) identify metabolites which discriminate between subjects with and without depression symptoms in the CSF and plasma and 2) how changes correlate between CSF and plasma.

2019-07-01 | MSV000084037 | GNPS

Expression data from human brain amygdala - including control samples and samples with major depression disorders (42 samples MD3_AMY)

Project description:Major depressive disorder is a heterogeneous illness with a mostly uncharacterized pathology. Large scale gene expression (transcriptome) analysis and genome-wide association studies (GWAS) for single nucleotide polymorphisms have generated a considerable amount of gene- and disease-related information, but heterogeneity and various sources of noise have limited the discovery of disease mechanisms. As systematic dataset integration is becoming essential, we developed methods and performed meta-clustering of gene coexpression links in 11 transcriptome studies from postmortem brains of human subjects with major depressive disorder (MDD) and non-psychiatric control subjects. We next sought enrichment in the top 50 meta-analyzed coexpression modules for genes otherwise identified by GWAS for various sets of disorders. One coexpression module of 88 genes was consistently and significantly associated with GWAS for MDD, other neuropsychiatric disorders and brain functions, and for medical illnesses with elevated clinical risk of depression, but not for other diseases (See publication for details). 42 total samples in 21 pairs were analyzed in postmortem tissue from the amygdala.

2014-05-16 | E-GEOD-54564 | biostudies-arrayexpress

Expression data from human brain amygdala - including control samples and samples with major depression disorders (28 samples MD1_AMY)

Project description:Major depressive disorder is a heterogeneous illness with a mostly uncharacterized pathology. Large scale gene expression (transcriptome) analysis and genome-wide association studies (GWAS) for single nucleotide polymorphisms have generated a considerable amount of gene- and disease-related information, but heterogeneity and various sources of noise have limited the discovery of disease mechanisms. As systematic dataset integration is becoming essential, we developed methods and performed meta-clustering of gene coexpression links in 11 transcriptome studies from postmortem brains of human subjects with major depressive disorder (MDD) and non-psychiatric control subjects. We next sought enrichment in the top 50 meta-analyzed coexpression modules for genes otherwise identified by GWAS for various sets of disorders. One coexpression module of 88 genes was consistently and significantly associated with GWAS for MDD, other neuropsychiatric disorders and brain functions, and for medical illnesses with elevated clinical risk of depression, but not for other diseases (See publication for details). 28 total samples in 14 pairs were analyzed in postmortem tissue from the amygdala.

2014-05-16 | E-GEOD-54566 | biostudies-arrayexpress

Proteomic profiles of neutrophils from Behcet's uveitis patients and their sex differences

Project description:A label-free proteomic analysis was performed on peripheral blood neutrophils from active BU patients without medication and gender- and age-matched healthy controls

2025-12-29 | PXD062006 | Pride

Transcriptional analysis of prefrontal area 9 in Parkinson's disease

Project description:Post mortem tissue was dissected from two groups of age and gender matched groups of Parkinson and Control subjects

2010-02-04 | GSE20168 | GEO